176 related articles for article (PubMed ID: 37791598)
21. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
22. ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury.
Cao J; Gaamouch FE; Meabon JS; Meeker KD; Zhu L; Zhong MB; Bendik J; Elder G; Jing P; Xia J; Luo W; Cook DG; Cai D
Sci Rep; 2017 Sep; 7(1):11372. PubMed ID: 28900205
[TBL] [Abstract][Full Text] [Related]
23. The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation.
Nelson MR; Liu P; Agrawal A; Yip O; Blumenfeld J; Traglia M; Kim MJ; Koutsodendris N; Rao A; Grone B; Hao Y; Yoon SY; Xu Q; De Leon S; Choenyi T; Thomas R; Lopera F; Quiroz YT; Arboleda-Velasquez JF; Reiman EM; Mahley RW; Huang Y
Nat Neurosci; 2023 Dec; 26(12):2104-2121. PubMed ID: 37957317
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.
Nishitsuji K; Hosono T; Nakamura T; Bu G; Michikawa M
J Biol Chem; 2011 May; 286(20):17536-42. PubMed ID: 21471207
[TBL] [Abstract][Full Text] [Related]
25. Exercise modulates APOE expression in brain cortex of female APOE3 and APOE4 targeted replacement mice.
Mulgrave VE; Alsayegh AA; Jaldi A; Omire-Mayor DT; James N; Ntekim O; Walters E; Akala EO; Allard JS
Neuropeptides; 2023 Feb; 97():102307. PubMed ID: 36434832
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E4 inhibits γ-secretase activity via binding to the γ-secretase complex.
Sun Y; Islam S; Gao Y; Nakamura T; Zou K; Michikawa M
J Neurochem; 2023 Mar; 164(6):858-874. PubMed ID: 36582176
[TBL] [Abstract][Full Text] [Related]
27. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
28. Effects of toxic apolipoprotein E fragments on Tau phosphorylation and cognitive impairment in neonatal mice under sevoflurane anesthesia.
Yu Y; Yang M; Zhuang X; Pan J; Zhao Y; Yu Y
Brain Behav; 2022 Aug; 12(8):e2702. PubMed ID: 35810473
[TBL] [Abstract][Full Text] [Related]
29. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
30. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
31. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
32. APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread.
Chen Y; Song S; Parhizkar S; Lord J; Zhu Y; Strickland MR; Wang C; Park J; Tabor GT; Jiang H; Li K; Davis AA; Yuede CM; Colonna M; Ulrich JD; Holtzman DM
Cell; 2024 Jan; 187(2):428-445.e20. PubMed ID: 38086389
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.
Johnson LA; Olsen RH; Merkens LS; DeBarber A; Steiner RD; Sullivan PM; Maeda N; Raber J
Neurobiol Dis; 2014 Apr; 64():150-62. PubMed ID: 24412220
[TBL] [Abstract][Full Text] [Related]
34. Quantitative Proteomic Analysis Reveals apoE4-Dependent Phosphorylation of the Actin-Regulating Protein VASP.
Cakir Z; Lord SJ; Zhou Y; Jang GM; Polacco BJ; Eckhardt M; Jimenez-Morales D; Newton BW; Orr AL; Johnson JR; da Cruz A; Mullins RD; Krogan NJ; Mahley RW; Swaney DL
Mol Cell Proteomics; 2023 May; 22(5):100541. PubMed ID: 37019383
[TBL] [Abstract][Full Text] [Related]
35. APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading.
Wang C; Nambiar A; Strickland MR; Lee C; Parhizkar S; Moore AC; Musiek ES; Ulrich JD; Holtzman DM
J Clin Invest; 2023 Jul; 133(14):. PubMed ID: 37279069
[TBL] [Abstract][Full Text] [Related]
36. Obesity Accelerates Alzheimer-Related Pathology in
Moser VA; Pike CJ
eNeuro; 2017; 4(3):. PubMed ID: 28612048
[TBL] [Abstract][Full Text] [Related]
37. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
39. Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer's disease pathogenesis in the brain during peripheral chronic inflammation.
Na H; Yang JB; Zhang Z; Gan Q; Tian H; Rajab IM; Potempa LA; Tao Q; Qiu WQ
Neurobiol Aging; 2023 Jul; 127():54-69. PubMed ID: 37060729
[TBL] [Abstract][Full Text] [Related]
40. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice.
Larramona-Arcas R; González-Arias C; Perea G; Gutiérrez A; Vitorica J; García-Barrera T; Gómez-Ariza JL; Pascua-Maestro R; Ganfornina MD; Kara E; Hudry E; Martinez-Vicente M; Vila M; Galea E; Masgrau R
Mol Neurodegener; 2020 Jun; 15(1):35. PubMed ID: 32517777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
